Cargando…

Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies

Bone disease, including osteolytic lesions and/or osteoporosis, is a common feature of multiple myeloma (MM). The consequences of skeletal involvement are severe pain, spinal cord compressions, and bone fractures, which have a dramatic impact on patients’ quality of life and, ultimately, survival. D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallet, Sonia, Filzmoser, Julia-Marie, Pecherstorfer, Martin, Podar, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321035/ https://www.ncbi.nlm.nih.gov/pubmed/30355994 http://dx.doi.org/10.3390/pharmaceutics10040202

Ejemplares similares

Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma
por: Pozzi, Samantha, et al.
Publicado: (2021)

Effect of cachexia on bone turnover in cancer patients: a case-control study
por: Zwickl, Hannes, et al.
Publicado: (2021)

JunB is a key regulator of multiple myeloma bone marrow angiogenesis
por: Fan, Fengjuan, et al.
Publicado: (2021)

Pathogenesis and treatment of multiple myeloma bone disease
por: Hiasa, Masahiro, et al.
Publicado: (2021)

Pathogenesis and Treatment of Myeloma-Related Bone Disease
por: Gau, Yuh-Ching, et al.
Publicado: (2022)

Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic Patients
por: Singer, Josef, et al.
Publicado: (2021)

Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
por: Teramachi, Jumpei, et al.
Publicado: (2023)

Relapsed/Refractory Multiple Myeloma in 2020/2021 and Beyond
por: Podar, Klaus, et al.
Publicado: (2021)

Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination—A Retrospective Cohort Study
por: Wirth, Stella Rosa Maria, et al.
Publicado: (2023)

Update on the pathogenesis and genetics of Paget’s disease of bone
por: Gennari, Luigi, et al.
Publicado: (2022)

Mathematical modelling of the pathogenesis of multiple myeloma-induced bone disease
por: Ji, Bing, et al.
Publicado: (2014)

Pathogenesis of bone disease in multiple myeloma: from bench to bedside
por: Terpos, Evangelos, et al.
Publicado: (2018)

The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma Pathophysiology
por: Fan, Fengjuan, et al.
Publicado: (2021)

Exosomes in the Pathogenesis and Treatment of Multiple Myeloma in the Context of the Bone Marrow Microenvironment
por: Chen, Tianzeng, et al.
Publicado: (2020)

Pathogenesis and treatment of multiple myeloma
por: Yang, Peipei, et al.
Publicado: (2022)

Pathway-Directed Therapy in Multiple Myeloma
por: John, Lukas, et al.
Publicado: (2021)

Multiple Myeloma (Part 2) - Update on The Approach to Bone Disease
por: Guedes, Alex, et al.
Publicado: (2023)

Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma
por: Woitge, H W, et al.
Publicado: (2001)

An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment
por: Lorenzo-Morales, Jacob, et al.
Publicado: (2015)

An update on necrotizing enterocolitis: pathogenesis and preventive strategies
por: Lee, Jang Hoon
Publicado: (2011)

Novel Local “Off-the-Shelf” Immunotherapy for the Treatment of Myeloma Bone Disease
por: Charvátová, Sandra, et al.
Publicado: (2023)

A Novel Role for CCL3 (MIP-1α) in Myeloma-induced Bone Disease via Osteocalcin Downregulation and Inhibition of Osteoblast Function
por: Vallet, Sonia, et al.
Publicado: (2011)

Update on the Pathogenesis, Clinical Diagnosis, and Treatment of Hirayama Disease
por: Wang, Hongwei, et al.
Publicado: (2022)

Caroli disease: an update on pathogenesis
por: Shi, Wen, et al.
Publicado: (2021)

New agents in the Treatment of Myeloma Bone Disease
por: Ring, Elizabeth S., et al.
Publicado: (2017)

Myeloma Bone Disease
por: Sanderson, Ralph D, et al.
Publicado: (2009)

Comparison of Technetium-99m-MIBI imaging with MRI for detection of spine involvement in patients with multiple myeloma
por: Mirzaei, Siroos, et al.
Publicado: (2003)

Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update
por: Abramson, Hanley N.
Publicado: (2018)

Analysis of Updates in Multiple Myeloma Treatment and Management
por: Nieto, Maria Jacqueline, et al.
Publicado: (2023)

Infantile Hemangiomas: An Update on Pathogenesis and Treatment
por: Kowalska, Małgorzata, et al.
Publicado: (2021)

The molecular pathogenesis of multiple myeloma
por: Bolli, Niccolò, et al.
Publicado: (2020)

Recent Progress of Exosomes in Multiple Myeloma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Strategies
por: Wang, Xi, et al.
Publicado: (2021)

An update on pathogenesis and clinical scenario for Parkinson’s disease: diagnosis and treatment
por: Adam, Hussaini, et al.
Publicado: (2023)

Attrition Rates in Multiple Myeloma Treatment under Real World Conditions—An Analysis from the Austrian Myeloma Registry (AMR)
por: Benda, Magdalena A., et al.
Publicado: (2023)

Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update
por: Nijhof, Inger S., et al.
Publicado: (2017)

Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies
por: Papageorgiou, Chrysoula, et al.
Publicado: (2018)

Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies
por: Zhang, Xinyuan, et al.
Publicado: (2023)

Novel Experimental Drugs for Treatment of Multiple Myeloma
por: Offidani, Massimo, et al.
Publicado: (2021)

Evolving treatment strategies for myeloma
por: Morgan, G J, et al.
Publicado: (2005)

Diverticular Disease: An Update on Pathogenesis and Management
por: Rezapour, Mona, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ce0trmq20i9315b11dslo62pcs